| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 06/26/2008 | WO2008075070A1 Sulfonamide derivatives for therapeutic use as fatty acid synthase inhibitors |
| 06/26/2008 | WO2008038251A3 3-aza-bicyclo[3.1.0]hexane derivatives |
| 06/26/2008 | US20080153869 2-hydroxy-1H-indol derivatives enzyme inhibitors for preventing or treating inflammation, inflammatory bowel disease, psoriasis, dementia related diseases Alzheimer's Disease, Cognitive Impairment, arthritis, neurodegenerative diseases, amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | CA2672893A1 Triazine derivatives and their therapeutical applications |
| 06/26/2008 | CA2672250A1 Antiviral indoles |
| 06/26/2008 | CA2671765A1 5- [4- (azetidin-3-yloxy) -phenyl] -2-phenyl-5h-thiazolo [5,4-c] pyridin-4-one derivatives and their use as mch receptor |
| 06/26/2008 | CA2671137A1 Carbonic anhydrase inhibitors derivatives |
| 06/25/2008 | EP1935885A2 Melanin concentrating hormone receptor ligands : substituted 1-benzyl-4-aryl piperazine analogues. |
| 06/25/2008 | EP1934233A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 06/25/2008 | EP1934223A1 Bicyclic aromatic compounds useful as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 |
| 06/25/2008 | EP1934180A2 3-cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 06/25/2008 | EP1933835A1 Pharmaceutically active tetrahydro-pyrrolo[1,2-b]isothiazole 1,1-dioxides |
| 06/25/2008 | CN101208352A Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 06/25/2008 | CN101208334A Novel cyclic amines |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/19/2008 | WO2008073370A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | WO2008072655A1 Imidazothiazole derivatives |
| 06/19/2008 | WO2008071981A1 Piperidines for the treatment of bacterial infections |
| 06/19/2008 | WO2008071961A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/19/2008 | WO2008043544A8 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
| 06/19/2008 | WO2007115929A8 Thiazolyl-dihydroquinazolines |
| 06/19/2008 | WO2006078621A9 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 06/19/2008 | US20080146609 5-[3-(6,8-Dibromo-1,2,3,4-tetrahydro-quinolin-4-ylamino)-propylamino]-4H-thieno [3,2-b]pyridin-7-one, used as inhibitors of bacterial methionyl tRNA synthetase, administered for the treatment of bacterial infections; therapy for Clostridium difficile based infections |
| 06/19/2008 | US20080146551 Antibacterial Agents |
| 06/19/2008 | US20080145334 Hepatitis c virus inhibitors |
| 06/19/2008 | CA2672565A1 Imidazothiazole derivatives |
| 06/19/2008 | CA2672295A1 Aspartyl protease inhibitors containing a tricyclic ring system |
| 06/19/2008 | CA2671485A1 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents |
| 06/18/2008 | EP1931627A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands |
| 06/17/2008 | US7388096 Crystalline forms of a factor Xa inhibitor |
| 06/17/2008 | US7388024 Indeno[2,1A]indenes and isoindolo[2,1-A]indoles |
| 06/17/2008 | CA2369947C Hydroxamic acid derivative |
| 06/12/2008 | WO2008068127A1 Thuggacin-type macrolide antibiotics and their use as antimycobacterial agents |
| 06/12/2008 | WO2008048648A3 Cb1-modulating compounds and their use |
| 06/12/2008 | WO2008039639A3 Substituted thienopyridone compounds with antibacterial activity |
| 06/12/2008 | WO2007143523A3 Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 06/12/2008 | WO2007115931A8 Thiazolyldihydrocyclopentapyrazoles for use as pi3-kinase inhibitors |
| 06/12/2008 | WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases |
| 06/12/2008 | US20080139541 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-(4-chloro)carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 06/11/2008 | EP1928887A1 Methods of preparing quinolone analogs |
| 06/11/2008 | EP1928886A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 06/11/2008 | EP1230235B1 Compounds with antibacterial and antiparasitic properties |
| 06/11/2008 | CN101195599A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols |
| 06/11/2008 | CN100393726C Process for preparing 2,4-disubstituted heterocyclo [4,5-e][1,2,4] thiadiazine derivatives |
| 06/10/2008 | US7385056 Directly hydrogenating a heteroaryl alpha-hydroxyacetamide in the presence of a strong acid, a halide and a catalyst; for example, the heteroaryl acetamide is zolpidem and the heteroaryl alpha-hydroxyacetamide is alpha-hydroxyzolpidem |
| 06/10/2008 | US7384965 Fused heterocyclic derivatives as PPAR modulators |
| 06/10/2008 | US7384951 Immunosuppressants; respiratory system disorders; asthma; chronic obstructive pulmonary disease |
| 06/10/2008 | US7384937 Antiarthritic agents; multiple sclerosis ; organ rejection ; antidiabetic agents; inflammatory bowel disorders; antiischemic agents; skin disorders |
| 06/10/2008 | US7384934 6-Fluoro-10-[3-(2-methoxy-ethyl)-4-methyl-piperazin-1-yl]-2-methyl-4H-3-thia-4,9-diaza-benzo[f]azulene; dopamine D2 and serotonin receptor anatagonist; neuroleptic agent, antidepressnt; psychological, bipolar disorders, psychosis, schizophrenia, acute mania |
| 06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 06/05/2008 | WO2008065626A2 3-heteroaryl (amino or amido)-1- (biphenyl or phenylthiazolyl) carbonylpiperidine derivativesas orexin receptor inhibitors |
| 06/05/2008 | WO2008043791A3 Thiophene derivatives for treating hepatitis c |
| 06/05/2008 | US20080132513 new mechanism of action, oral bioavailability and/or reduced side effects; Ca2+-release-activated Ca2+ channels inhibitors; IL-2, IL-4, IL-5, IL-13, GM-CSF, TNF- alpha , and IFN gamma inhibitors; immunosuppressant |
| 06/05/2008 | US20080132496 Anticoagulants; factor Xa inhibitors; compounds are N-(benzimidazolyl, imidazo(4,5-b)pyridyl- or indolyl)-substituted benzamides |
| 06/05/2008 | US20080132479 Oxime Derivative and Preparations Thereof |
| 06/05/2008 | CA2669060A1 Piperidine compounds |
| 06/05/2008 | CA2668579A1 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 06/04/2008 | EP1926719A2 2-aniline-4-aryl substituted thiazole derivatives |
| 06/04/2008 | CN101193899A Monomers, oligomers and polymers of thieno (3, 4-D) thiazole |
| 06/04/2008 | CN101193898A Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3H)-one derivatives |
| 06/04/2008 | CN101193897A Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| 06/03/2008 | US7381720 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 06/03/2008 | US7381585 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 05/29/2008 | WO2008063668A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | WO2008063287A2 Novel imidazothiazoles and imidazoxazoles |
| 05/29/2008 | WO2008062739A1 Pyrazoles and use thereof as drugs |
| 05/29/2008 | WO2008062463A2 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-l,2-thiazine-6-sulfonamide-l,l-dioxide |
| 05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2666405A1 Improved process for the preparation of (r)-(+)-4-(ethyiamino)-3,4-dihydro-2-(3- methoxypropyl)-2h-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide |
| 05/28/2008 | EP1537115B1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 05/28/2008 | CN101189243A Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378426 Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
| 05/22/2008 | WO2008059512A1 Process for preparation of prulifloxacin using novel intermediates |
| 05/22/2008 | WO2008059368A2 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer |
| 05/22/2008 | WO2008058641A1 Imidazo[2, 1-b]thiazoles and their use as pharmaceuticals |
| 05/22/2008 | WO2008036420A3 9-(heteroaryl)-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents |
| 05/22/2008 | US20080119646 Prepared by cyclization of substituted indole-S,S-dioxide derivatine; for example, 8-methyl-3-(4-methyl-piperazin-1-ylmethyl)-1,2-benzothiazino[2,3,4-ab]indole-S,S-dioxide; may be useful as medicaments |
| 05/22/2008 | CA2669886A1 Compounds useful as protein kinase inhibitors |
| 05/21/2008 | EP1923062A1 Imidazo[2,1-b]thiazoles and their use as pharmaceuticals |
| 05/21/2008 | EP1922318A1 Pyridopyrimidine derivatives as pde4 inhibitors for the treatment of inflammatory and' immune diseases |
| 05/21/2008 | EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 05/21/2008 | EP1562958B1 N-sulfonylaminothiazole |
| 05/21/2008 | DE102007053198A1 Photoinitiatoren für strahlungshärtbare Beschichtungsmassen Photoinitiators for radiation-curable coating compositions |
| 05/20/2008 | US7375220 Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | CA2453123C Intermediate for condensed benzazepine derivatives |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2205664C Indole derivatives and medicinal use thereof |
| 05/15/2008 | WO2008057875A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008008310A3 Tyrosine kinase inhibitors |
| 05/15/2008 | US20080114164 Imidazothiazole Derivatives and Process for Producing the Same |
| 05/15/2008 | US20080113971 improved potency; reduced undesirable side effects; pain, inflammation, arthritis etc; ethyl 1-(2-aminoethyl)-3-pyridin-4-yl-1H-pyrazole-5-carboxylate dihydrochloride |
| 05/14/2008 | EP1485365B1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 05/14/2008 | CN101180300A New isothiazoloquinolones and related compounds as anti-infective agents |
| 05/13/2008 | US7371864 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one for treating thromboembolic disorders |
| 05/13/2008 | US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O |
| 05/08/2008 | WO2008054749A1 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |